IXHL vs JANX

Incannex Healthcare Inc. vs Janux Therapeutics, Inc. — Valuation Comparison 2026

IXHL

Pharmaceutical Preparations
Incannex Healthcare Inc.
Quality
5.3
out of 10
Value Trap
12
SAFE
Price
$3.35
Last close
Models
9/13
Active
VS

JANX

Pharmaceutical Preparations
Janux Therapeutics, Inc.
Quality
5.4
out of 10
Value Trap
24
SAFE
Price
$14.59
Last close
Models
9/13
Active

Model-by-Model Comparison

ModelType IXHL Fair ValueIXHL Upside JANX Fair ValueJANX Upside
Bayesian DCF Intrinsic $4.37 +30.4% $4.18 -71.3%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $6.70 +100.1% $9.03 -38.1%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for IXHL vs JANX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

IXHL vs JANX — Which Stock Is More Undervalued?

JANX scores higher with a 5.4/10 quality rating vs IXHL's 5.3/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Incannex Healthcare Inc. (IXHL) and Janux Therapeutics, Inc. (JANX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

IXHL currently trades at $3.35 with a QOC of 5.3/10, while JANX trades at $14.59 with a QOC of 5.4/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).